Request a demo specialized to your need.
A red signal appears on a KRI dashboard. A weekly review gets scheduled. The next meeting is spent figuring out what the signal actually means. By the time action is taken, the study has already lost ground.
KRI dashboards sit above disconnected systems not inside a unified operating model. When CTMS, finance, and eTMF operate separately, a single site activation delay shows up differently in each:
- A timeline problem in CTMS
- A startup payment issue in financial management
- A document-readiness gap in eTMF
Reconciling those three views takes time your team does not have. And while the reconciliation is happening, the study keeps moving.
For VPs, Directors, and Heads of Clinical Ops running startup heavy portfolios across the US and Europe, that separation is not a minor inconvenience. It is a compounding risk.
The Difference Between a Dashboard and a Control Surface
A KRI becomes actionable only when teams can see the signal and understand what is driving it without leaving the system to find out.
When a site trends off course, Clinical Operations leaders need to know immediately whether the issue sits in:
- Startup execution and milestone timing
- Payment conditions or accrual lag
- Essential record completeness in the TMF
- Monitoring follow-up gaps
That diagnosis is impossible when CTMS, Clinical Trial Financial Management, and eTMF hold separate pieces of the answer.
Cloudbyz connects all three on a single Salesforce-native spine. A delayed activation is not just a red tile it can be traced to unresolved startup fees, slow document readiness, or inconsistent country-level execution. A quality signal is not trapped in a dashboard. It is tied to the operating record behind it.
That is what makes risk-based monitoring actually usable.
What ICH E6(R3) Expects And What Most Platforms Cannot Deliver
ICH E6(R3) is direct: sponsors should be able to identify what matters, interpret it proportionately, and respond in a documented way.
Collecting dashboards is not enough. Leaders need to show how signals were interpreted, escalated, and managed with an audit trail that supports it.
A unified CTMS makes that possible because startup execution, financial movement, monitoring activity, and documentary evidence share one data and audit model. The signal can be followed into the evidence behind it. Action can be tracked without leaving the operating environment.
The EMA's position on computerized systems reinforces this reliable, robust, and governed trial infrastructure is a regulatory expectation, not a technical preference.
The Bottom Line for Clinical Operations Leaders
More KRI indicators do not produce faster decisions. A unified operating model does.
When CTMS, CTFM, and eTMF share one platform, the gap between seeing a signal and acting on it closes because the context, the evidence, and the action path are all in the same place.
For biotech sponsors and CROs operating across multiple countries and sites, that is not a convenience. It is a competitive advantage while the study is still moving.
Cloudbyz is Salesforce-native unified eClinical platform connecting CTMS, Clinical Trial Financial Management, and eTMF in one operating model. If your team is managing risk signals across disconnected systems, we'd like to spend 30 minutes using your portfolio as the reference point.
Subscribe to our Newsletter
